Prologis building GSK’s new R&D centre in Cambridge
GlaxoSmithKline, the pharmaceutical giant, has announced plans to move 1,000 scientists from Stevenage to a new 30,000 sq.m R&D centre in the Cambridge Biomedical Campus. Prologis is the development partner for the new centre, which is planned across three interconnected buildings and is part of GSK’s plan to accelerate its research and development pipeline.
You have reached premium content
Our readers look to Real Asset Insight to stay informed about the issues that matter in the real asset markets. Log in, start a free trial or subscribe below.
Stay ahead of your competitors with the latest news, market insights and in-depth analysis of the issues that matter in Real Assets.
14 DAY TRIAL MEMBERSHIP
Be part of the leading real asset community!
Get your free trial now
SUBSCRIBE NOW
Stay ahead of your competitors with the latest news, market insights and in-depth analysis of the issues that matter in Real Assets.
Be part of the leading real asset community and subscribe now!
Subscribe now
